Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same
    2.
    发明授权
    Peptides involved in the SCF c-Kit signaling pathway and compositions comprising same 有权
    涉及SCF c-Kit信号通路的肽和包含其的组合物

    公开(公告)号:US08962565B2

    公开(公告)日:2015-02-24

    申请号:US13982386

    申请日:2012-01-30

    摘要: Peptide compounds of general formula (I) R1-(AA)n-X1—X2—X3-Asp-Leu-Lys-Lys-X4—X5-(AA)p-R2, cosmetic or pharmaceutical compositions comprising at least one peptide compound of general formula (I) in a physiologically acceptable medium, and methods for cosmetic treatment of skin are disclosed. The peptide compounds of general formula (I) were demonstrated to be agents making it possible to influence the pigmentation of the skin and skin appendages, by ensuring optimal transfer of the melanosomes to the keratinocytes, so as to make the skin tone uniform owing to an effect on the SCF/c-Kit signaling pathway. The compounds, compositions, and methods treat or attenuate age-related pigmentation defects and the effects of photoaging on the skin.

    摘要翻译: 通式(I)R1-(AA)n-X1-X2-X3-Asp-Leu-Lys-Lys-X4-X5-(AA)p-R2的肽化合物,包含至少一种肽化合物的化妆品或药物组合物 通式(I)的生理学上可接受的介质,以及皮肤美容治疗方法。 证明通式(I)的肽化合物是通过确保黑素体最佳转移到角质形成细胞而使皮肤和皮肤附着物的色素沉着成为可能的原因,从而使肤色均匀 对SCF / c-Kit信号通路的作用。 化合物,组合物和方法治疗或减轻年龄相关色素沉着缺陷和光老化对皮肤的影响。

    Proteasome-activating lightening peptides and compositions containing same
    7.
    发明授权
    Proteasome-activating lightening peptides and compositions containing same 有权
    蛋白酶体激活增亮肽及其组合物

    公开(公告)号:US08530623B2

    公开(公告)日:2013-09-10

    申请号:US13262451

    申请日:2010-04-01

    IPC分类号: C07K5/093 C07K7/06 A61K8/64

    摘要: The present invention relates to depigmenting, lightening and/or whitening peptidic compounds of general formula (I) R1—X1—X2-Asp-Cys-Arg-X3—X4-(AA)p-R2. In addition, the present invention relates to, on the one hand, a cosmetic or pharmaceutical composition comprising at least one peptide of general formula (I), in a cosmetically or dermatologically acceptable medium and, on the other hand, its utilization to depigment, lighten and/or whiten the skin and prevent or treat hyperpigmentation blemishes as well as cutaneous signs due to photo-aging. Lastly, the invention applies to a cosmetic treatment method utilizing said peptidic compounds.

    摘要翻译: 本发明涉及通式(Ⅰ)R1-X1-X2-Asp-Cys-Arg-X3-X4-(AA)p-R2的脱色,减亮和/或增白肽化合物。 此外,本发明一方面涉及包含至少一种通式(I)的肽的化妆品或药物组合物,在化妆品或皮肤病学可接受的介质中,另一方面涉及其用于脱色, 减轻和/或增白皮肤,防止或治疗色素沉着过度的瑕疵以及由于光老化引起的皮肤征象。 最后,本发明适用于利用所述肽化合物的美容治疗方法。

    Activating peptide of the synthesis of aquaporins and cosmetic and/or pharmaceutical composition containing it
    8.
    发明授权
    Activating peptide of the synthesis of aquaporins and cosmetic and/or pharmaceutical composition containing it 有权
    激活水通道蛋白合成肽和含有它的化妆品和/或药物组合物

    公开(公告)号:US08450456B2

    公开(公告)日:2013-05-28

    申请号:US12808266

    申请日:2008-12-17

    IPC分类号: C07K5/10

    摘要: The present invention concerns a peptide of the general formula (I):R1-(AA)n-X1—X2—X3-Pro-X4—X5—X7-(AA)p-R2, capable of activating the synthesis of proteins of the family of aquaporins.The present invention also concerns a cosmetic, nutraceutical or pharmaceutical composition, comprising a peptide of general formula (I) as active principle. The invention also relates to the use of this new active principle in a cosmetic or nutraceutical composition, intended to improve the moisturizing and the barrier function of the epidermis and intended to stimulate cutaneous regeneration. The invention also relates to the use of this new active principle to realize a pharmaceutical composition, and in particular a dermatological composition, intended to regulate and/or stimulate the activity of the aquaporins and to thus treat the pathological dryness of the skin or mucosa. The invention also relates to a method of cosmetic treatment intended to prevent or combat against dryness of the skin and mucosa, and the manifestations of cutaneous ageing.

    摘要翻译: 本发明涉及通式(I)的肽:R1-(AA)n-X1-X2-X3-Pro-X4-X5-X7-(AA)p-R2,其能够活化蛋白质的合成 水通道蛋白家族。 本发明还涉及包含通式(I)的肽作为活性成分的化妆品,营养药物或药物组合物。 本发明还涉及这种新的活性成分在化妆品或营养组合物中的用途,其旨在改善表皮的保湿和屏障功能并且旨在刺激皮肤再生。 本发明还涉及这种新的活性成分用于实现旨在调节和/或刺激水通道蛋白的活性并因此治疗皮肤或粘膜的病理干燥的药物组合物,特别是皮肤病学组合物的用途。 本发明还涉及旨在预防或防止皮肤和粘膜干燥以及皮肤老化表现的美容治疗方法。